1. The latest news: Biogen not leaving amyloid beta theory yet; new clinical trial starting — Digital health just had a record year — Conatus and Novartis suffer another NASH flop -- See more on our front page news

    Plus NEW BOARDS added recently
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

What in tarnation is with this ride along with aristada reps thing?

Discussion in 'Alkermes' started by anonymous, Mar 16, 2019 at 11:34 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Don't they know people riding with us just slows us down? Nothing they are making us do makes sense. Tell us we need focus and ride along help with one product and then make us concentrate on another all while having people ride with us and slow us down. WFT? Who's plan was this? Focus on this product because we really need to increase market share, but wait! Also learn another product and then focus 20% of you time on that one after you learn it. Then all these people will be working with you because we really need to increase share in the original one and the "ride along helpers" do nothing but slow us down.

    Just think about what a screwed up plan that is. Go this way because it is the most important thing then at the same time go another way for 20% of the time. Then add 195 pounds of weight on your back to help you detail the first product. Do our leaders know what is going on?!?!
  2. anonymous

    anonymous Guest

    I mean, I see your point, but this is very poorly written.
  3. anonymous

    anonymous Guest

    No they don’t. Another antiquated Big Pharma reach and frequency tactic. So so JR and ALKS. Next thing we know managers will be in the back seat for a 3 way ride along
  4. anonymous

    anonymous Guest